Test Price
3,000 AED✅ Home Collection Available
Blood Coagulation Panel Genetic Test in UAE – NGS 84-Gene Analysis
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited next‑generation sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM.
- Clinical Guidance: Telephonic post-test clinical guidance included with DHA-licensed specialist interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Price: 3,000 AED (inclusive of test, home collection, and telephonic consultation).
Test Overview & Methodology
The Blood Coagulation Panel Genetic Test is a comprehensive next‑generation sequencing assay that simultaneously analyses 84 genes associated with inherited bleeding, thrombotic, and platelet disorders. It delivers a definitive molecular diagnosis for conditions such as haemophilia, von Willebrand disease, hereditary thrombophilia, and rare coagulation factor deficiencies, enabling personalised treatment and family risk assessment.
| Feature | Our Test (NGS Coagulation Panel) | Closest Alternative (Single‑Gene / Sanger) |
|---|---|---|
| Precision | >99% analytical sensitivity & specificity with comprehensive 84‑gene coverage | Limited to one or few genes; may miss causative variants in other loci |
| Method | Next‑Generation Sequencing (NGS), clinically validated per ACMG guidelines | Sanger sequencing; lower throughput, longer TAT for multi‑gene queries |
| Speed | 3–4 weeks from sample receipt | Often >8 weeks when multiple genes are tested sequentially |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I often see patients and families seeking clarity on inherited coagulation disorders. This NGS panel provides a comprehensive molecular map, but it must always be interpreted in the context of personal and family bleeding or clotting history. Our team is committed to guiding you through results and next steps with compassion and precision.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Safety Advisory
Do not discontinue prescribed anticoagulant, antiplatelet, or any other medication without consulting your doctor. Genetic results complement clinical judgment; abrupt cessation of blood thinners may lead to life‑threatening thrombosis or haemorrhage.
Exclusion Criteria & Emergency Red Flags
- Active acute bleeding or unstable haemodynamics – seek emergency care immediately.
- Known severe anaemia (Hb <8 g/dL) or platelet count <20 × 10⁹/L – requires clinical stabilisation before collection.
- Current high‑dose anticoagulation that cannot be safely paused for venipuncture (discuss with your physician).
- ER Red Flags: sudden severe headache, unilateral leg swelling with pain, chest pain with shortness of breath, or heavy uncontrolled bleeding – call 998 or visit the nearest Emergency Department.
Patient FAQ & Clinical Guidance
1. What exactly does the Blood Coagulation NGS Panel test for?
This advanced genetic test simultaneously screens 84 coagulation‑related genes for inherited mutations causing bleeding or clotting disorders, including haemophilia, von Willebrand disease, and thrombophilia.
2. How should I prepare for the blood draw and is genetic counseling required?
No fasting is necessary; however, a pre‑test genetic counseling session is mandatory to draw an accurate family pedigree and ensure informed consent. This is conducted via telemedicine at no extra cost.
3. How long will results take and will a doctor explain them to me?
Results are typically available within 3 to 4 weeks from sample receipt. A telephonic consultation with a DHA‑licensed specialist (geneticist or haematologist) is included to explain the findings and recommend next steps.
UAE Regulatory & Data Privacy Adherence
All genetic testing at DNA Labs UAE is conducted in full compliance with UAE federal laws governing personal data and health information:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensures your genetic data is collected, stored, and processed securely, with explicit consent and restricted access.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – mandates electronic health record security and data confidentiality across all digital platforms.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – governs clinical safety, patient consent, and professional accountability throughout the testing process.
Your privacy is paramount; genetic data is never shared with third parties without your explicit written authorization.
Clinical & Logistical Metadata
| Test Name | Blood Coagulation Panel Genetic Test (84-Gene NGS) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (Illumina platform), ACMG‑aligned variant interpretation |
| ICD-10-CM Code | D68.9 (Coagulation defect, unspecified) |
| LOINC Code | 81305-8 (Coagulation factor deficiency panel) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians